Overview and Scope
Cell counting refers to any of techniques used for counting cells or quantification of cells in the life sciences for diagnosis and treatment. Cell counting is used in monitoring cell health and proliferation rate assessing immortalization or transformation, transfection or infection, seeding cells for subsequent experiments, and preparing for cell-based assays.
Sizing and Forecast
The cell counting market size has grown strongly in recent years. It will grow from <b>$9.96 billion in 2023 to $10.87 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. </b> The growth in the historic period can be attributed to growth in biomedical research, increased clinical diagnostics, expanded pharmaceutical industry, increased cancer research, and increased aging population.
The cell counting market size is expected to see strong growth in the next few years. It will grow to <b>$15.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. </b> The growth in the forecast period can be attributed to increasing focus on precision medicine, grwoing adoption of regenerative medicine, increasing point-of-care testing, and growing stem cell research. Major trends in the forecast period include technological advancements, product innovations, ai integration, automation technology solutions, strategic collaborations.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report
Segmentation & Regional Insights
The cell counting market covered in this report is segmented –
1) By Consumables And Accessories: Media, Sera And Reagents, Assay Kits, Microplates, Accessories, Other Consumables
2) By Product: Spectrophotometers, Single-Mode Readers, Multi-Mode Readers, Cell Counters, Automated Cell Counters, Hemocytometers, Manual Cell Counters, Flow Cytometers, Hematology Analyzers
3) By Application: Research Applications, Clinical And Diagnostic Applications, Industrial Applications
4) By End-User: Hospitals And Diagnostic, Research Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users
<b>North America</b> was the largest region in the cell counting market in 2023. <b>Asia-Pacific</b> is expected to be the fastest-growing region in the forecast period. The regions covered in the cell counting market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6489&type=smp
Major Driver Impacting Market Growth
The growing prevalence of cancer amongst the global population is the major factor expected to drive the growth of the cell counting market. Changing lifestyle and eating habits, and non-maintaining of healthy body weight is the reason for chronic diseases and other chronic infections have the risk factors for cancer. Cancer is caused by various factors such as smoking, radiation, viruses, cancer-causing chemicals (carcinogens), obesity, hormones, chronic inflammation, and a lack of exercise. The growing population and exposure to the infection lead to chronic diseases. The need for celling counting increases as there is an increase in the prevalence of cancer. For instance, in January 2022, according to the American Cancer Society, a US-based non-profit healthcare organization devoted to the eradication of cancer, on average, 1,670 people will die from cancer each day in the United States, where there will be 1.9 million new cases and 609,360 deaths from the disease in 2022. Whereas in 2021, it has been estimated as 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the US show increasing growth in chronic diseases in the country. Therefore, the growing prevalence of cancer amongst the global population drives the cell counting market growth.
Key Industry Players
Major companies operating in the cell counting market include <b> Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Olympus Corporation, HORIBA Ltd., Logos Biosystems Inc., Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., BioTek Instruments Inc., DeNovix Inc., Sysmex Corporation, Nexcelom Bioscience LLC, Beckman Coulter Inc., Roche Diagnostics International Ltd., Miltenyi Biotec GmbH, AccuBioTech Co. Ltd., ChemoMetec A/S, Countstar Microscopy Systems, Luminex Corporation, NanoEnTek Inc., Partec GmbH, Advanced Instruments Inc., Analytik Jena AG, Integra Biosciences AG, Meridian Bioscience Inc., Promega Corporation, Sartorius AG </b>
The cell counting market report table of contents includes:
1. Executive Summary
2. Cell Counting Market Characteristics
3. Cell Counting Market Trends And Strategies
4. Cell Counting Market – Macro Economic Scenario
5. Global Cell Counting Market Size and Growth
.
.
.
31. Global Cell Counting Market Competitive Benchmarking
32. Global Cell Counting Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Cell Counting Market
34. Cell Counting Market Future Outlook and Potential Analysis
35. Appendix
Top Major Players:
Thermo Fisher Scientific Inc
Merck KGaA
PerkinElmer Inc.
Bio-Rad Laboratories Inc
Danaher Corporation
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
